Literature DB >> 17597708

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.

Brandie Heald1, Joanne M Hilden, Kevin Zbuk, Alice Norton, Paresh Vyas, Karl S Theil, Charis Eng.   

Abstract

BACKGROUND: A 34-year-old woman was referred for evaluation of a recent stillborn male fetus, gestational age 27 6/7 weeks, found to have congenital myeloid leukemia at autopsy. Autopsy findings included high weight for gestational age, hepatomegaly, and extensive intravascular leukemic infiltrates in the placenta, heart, liver, thymus, lung, kidneys, and brain. Genetic consultation and examination of photographs of the fetus revealed dysmorphic features. INVESTIGATIONS: Immunoperoxidase staining of placental tissue, fluorescence in situ hybridization of paraffin-embedded sections of the placenta using probes for t(12;21)(p13;q22), t(8;21)(q22;q22) and t/del(11q23), cytogenetic analysis of fetal tissue (tendon), sequence analysis of GATA1 in placental leukemic cells, and parental chromosome studies. DIAGNOSIS: Down syndrome with in utero onset of GATA1 mutation-positive severe transient myeloproliferative disorder/acute megakaryoblastic leukemia. MANAGEMENT: Genetic counseling for the recurrence risk of Down syndrome on the basis of maternal age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597708     DOI: 10.1038/ncponc0876

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  4 in total

1.  Transient abnormal myelopoiesis/acute megakaryoblastic leukemia diagnosed in the placenta of a stillborn Down syndrome fetus with targeted next-generation sequencing.

Authors:  B Federmann; A Fasan; K O Kagan; S Haen; F Fend
Journal:  Leukemia       Date:  2014-09-02       Impact factor: 11.528

2.  Myeloid cell thrombus and fetal vascular malperfusion in placentas with transient abnormal myelopoiesis.

Authors:  Kayo Tomimori; Yuki Kodama; Hiroyuki Tanaka; Atushi Yamashita; Toshihiro Gi; Yujiro Asada; Koutarou Doi; Shinji Katsuragi; Yuichiro Sato
Journal:  Virchows Arch       Date:  2022-02-24       Impact factor: 4.064

Review 3.  The renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage.

Authors:  Alán Alpár; Johannes Attems; Jan Mulder; Tomas Hökfelt; Tibor Harkany
Journal:  Cell Signal       Date:  2011-10-01       Impact factor: 4.315

Review 4.  The impact of trisomy 21 on foetal haematopoiesis.

Authors:  Irene Roberts; David O'Connor; Anindita Roy; Gillian Cowan; Paresh Vyas
Journal:  Blood Cells Mol Dis       Date:  2013-08-07       Impact factor: 3.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.